bulevirtide

Also known as Hepcludex, Myrcludex B

Bulevirtide, sold under the brand name Hepcludex, is an antiviral medication used for the treatment of chronic hepatitis D (in the presence of hepatitis B).

Clinical Trials

23 registered

PHASE2COMPLETED
Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)Gilead Sciences · NCT03852433
PHASE3RECRUITING
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With BulevirtideVir Biotechnology, Inc. · NCT07128550
ACTIVE_NOT_RECRUITING
Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)Hannover Medical School · NCT04863703
PHASE2ACTIVE_NOT_RECRUITING
A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV InfectionVir Biotechnology, Inc. · NCT07142811
COMPLETED
Assessment of Response and Safety of Bulevirtide Treatment in Patients With Chronic Delta Virus InfectionUniversity of Molise · NCT07116044
RECRUITING
Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With BulvertideFondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07429864

via ClinicalTrials.gov

Wikidata facts

Show 1 more fact

Commons category: Bulevirtide

via Wikidata · CC0

~2 min read

Article

5 sections

Contents

Medical uses
Pharmacology
Mechanism of action
Structural formula
References

Bulevirtide, sold under the brand name Hepcludex, is an antiviral medication used for the treatment of chronic hepatitis D (in the presence of hepatitis B).

The most common side effects include raised levels of bile salts in the blood and reactions at the site of injection.